Cargando…

Proceedings: A comparison of the cell killing in the mouse after exposure to ftorafur and to 5-fluorouracil.

Detalles Bibliográficos
Autores principales:	Van Putten, L. M., Kram-Idsenga, L. K., Pijpers-de Bruin, M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1974
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009237/ https://www.ncbi.nlm.nih.gov/pubmed/4419296

Ejemplares similares

Proceedings: Measurement of blood flow in the mouse tail after irradiation.
por: de Rutter, J., et al.
Publicado: (1975)

Proceedings: Identification of hypoxic mouse bone marrow CFU in vivo.
por: Keizer, H. J., et al.
Publicado: (1975)

Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study
por: Bajetta, E, et al.
Publicado: (2007)

‘A phase II study of oral uracil/ftorafur (UFT®) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer’
por: Bennouna, J, et al.
Publicado: (2006)

The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial.
por: Blomqvist, C., et al.
Publicado: (1992)

Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols
por: De Angelis, Paula M, et al.
Publicado: (2004)

Proceedings: Radiation and drugs; various mechanisms of interactions.
por: van Putten, L. M.
Publicado: (1975)

A Mouse Model of Dilated Cardiomyopathy Produced by Isoproterenol Acute Exposure Followed by 5-Fluorouracil Administration
por: Salerno, Nadia, et al.
Publicado: (2023)

Immunohistochemical analysis of organic anion transporter 2 and reduced folate carrier 1 in colorectal cancer: Significance as a predictor of response to oral uracil/ftorafur plus leucovorin chemotherapy
por: NISHINO, SATOSHI, et al.
Publicado: (2013)

In vivo cell synchrony in the L1210 mouse leukaemia studied with 5-fluorouracil or 5-fluorouracil followed by cold thymidine infusion.
por: Camplejohn, R. S., et al.
Publicado: (1977)

Comparison of CVF (Cyclophosphamide+Vinorelbine+5-Fluorouracil) and CMF (Cyclophosphamide+Methotrexate+5-Fluorouracil) Adjuvant Chemotherapy in Early Breast Cancer
por: Gwak, Geumhee, et al.
Publicado: (2011)

5-Fluorouracil Rechallenge After Cardiotoxicity
por: Desai, Aakash, et al.
Publicado: (2020)

In vitro targeting and selective killing of mcf-7 and colo320dm cells by 5-fluorouracil anchored to carboxylated SWCNTs and MWCNTs
por: Kamble, Rutuja V., et al.
Publicado: (2021)

Effects of the Plasma Concentration of 5‐Fluorouracil and the Duration of Continuous Venous Infusion of 5‐Fluorouracil with an Inhibitor of 5‐Fluorouracil Degradation on Yoshida Sarcomas in Rats
por: Fujii, Setsuro, et al.
Publicado: (1989)

Chemotherapeutic agent 5-fluorouracil increases survival of SOD1 mouse model of ALS
por: Rando, Amaya, et al.
Publicado: (2019)

Bioavailability and feasibility of subcutaneous 5-fluorouracil.
por: Borner, M. M., et al.
Publicado: (1993)

5-Fluorouracil Cardiotoxicity: Known But Unknown
por: Brell, Joanna M.
Publicado: (2021)

Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
por: Kim, Yeon-Joo, et al.
Publicado: (2013)

Comparison of Intralesional Triamcinolone Acetonide, 5-Fluorouracil, and Their Combination in Treatment of Keloids
por: Srivastava, Sunil, et al.
Publicado: (2018)

Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer
por: Aitini, Enrico, et al.
Publicado: (2012)

Hyperammonemia Secondary to 5-Fluorouracil
por: Scott, Ashley, et al.
Publicado: (2023)

A Comparative Study of the Efficacy of Intralesional 5 Fluorouracil vs Combination of 5 Fluorouracil with Triamcinolone Acetonide in Keloids
por: Monteiro, Rochelle C, et al.
Publicado: (2022)

Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2(+) Breast Cancer Cells to 5-Fluorouracil
por: Yi, Jianing, et al.
Publicado: (2020)

Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer
por: Chau, I, et al.
Publicado: (2001)

Induced miR‐31 by 5‐fluorouracil exposure contributes to the resistance in colorectal tumors
por: Nakagawa, Yoshihito, et al.
Publicado: (2019)

Porokeratoma treated with topical 5% 5-fluorouracil cream
por: Li, Steve S., et al.
Publicado: (2021)

Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes.
por: Peters, G. J., et al.
Publicado: (1989)

5-Fluorouracil Induces Diarrhea with Changes in the Expression of Inflammatory Cytokines and Aquaporins in Mouse Intestines
por: Sakai, Hiroyasu, et al.
Publicado: (2013)

Fatty acids inhibit anticancer effects of 5-fluorouracil in mouse cancer cell lines
por: Tanabe, Eriko, et al.
Publicado: (2017)

An elemental diet protects mouse salivary glands from 5-fluorouracil-induced atrophy
por: Harada, Koji, et al.
Publicado: (2022)

Letter: Blood levels of 5-fluorouracil during intravenous infusion.
por: Kawai, M., et al.
Publicado: (1976)

Corneal Epithelial Hyperplasia after 5-Fluorouracil Injection
por: Bukhari, Dania A., et al.
Publicado: (2018)

Supramolecular Tripeptide Hydrogel Assembly with 5-Fluorouracil
por: Parisi, Evelina, et al.
Publicado: (2019)

Influence of duration of exposure to 5-fluorouracil on antiproliferating activity against cultured murine lymphoma cells.
por: Kanzawa, F., et al.
Publicado: (1981)

Prolonged exposure of colon cancer cells to 5-fluorouracil nanoparticles improves its anticancer activity
por: Tawfik, Essam, et al.
Publicado: (2017)

5-fluorouracil and cardiotoxicity: a review
por: Sara, Jaskanwal D., et al.
Publicado: (2018)

5-Fluorouracil-induced vasospastic angina
por: Ayyildiz, Orhan, et al.
Publicado: (2005)

Fluorouracil (5-FU)-induced Cardiomyopathy
por: Thalambedu, Nishanth, et al.
Publicado: (2019)

Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines
por: Shiga, Taro, et al.
Publicado: (2020)

5-Fluorouracil–Induced Coronary Vasospasm
por: Arya, Sumedha, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4aslg8p3ofq7sr6tbs9r30do8l